Autologous Cancer Cell-Derived Extracellular Vesicles as Drug-Delivery Systems: A Systematic Review of Preclinical and Clinical Findings and Translational Implications

References

• Siegel RL , MillerKD, JemalA. Cancer statistics, 2018. CA Cancer J. Clin.68 (1), 7–30 (2018).
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L , BlanchetteJO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug. Deliver. Rev.64, 206–212 (2012).
   Web of Science ®Google Scholar
• Allen TM , CullisPR. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug. Deliver. Rev.65 (1), 36–48 (2013).
   PubMed Web of Science ®Google Scholar
• Pattni BS , ChupinVV, TorchilinVP. New developments in liposomal drug delivery. Chem. Rev.115 (19), 10938–10966 (2015).
   PubMed Web of Science ®Google Scholar
• Zheng G , ChenJ, LiH, GlicksonJD. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl Acad. Sci. USA102 (49), 17757–17762 (2005).
   PubMed Web of Science ®Google Scholar
• Roberts TC , EzzatK, El AndaloussiS, WeinbergMS. Synthetic SiRNA delivery: progress and prospects. Methods Mol. Biol.1364, 291–310 (2016).
   PubMedGoogle Scholar
• Wilhelm S , TavaresAJ, DaiQet al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater.1 (5), 16014 (2016).
   Web of Science ®Google Scholar
• Cho K , WangX, NieS, ChenZG, ShinDM. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res.14 (5), 1310–1316 (2008).
   PubMed Web of Science ®Google Scholar
• Vader P , MolEA, PasterkampG, SchiffelersRM. Extracellular vesicles for drug delivery. Adv. Drug. Deliver. Rev.106, 148–156 (2016).
   PubMed Web of Science ®Google Scholar
• Batrakova EV , KimMS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J. Control. Rel.219, 396–405 (2015).
   PubMed Web of Science ®Google Scholar
• Van Niel G , D’angeloG, RaposoG. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell. Bio.19 (4), 213–228 (2018).
   PubMed Web of Science ®Google Scholar
• Colombo M , RaposoG, TheryC. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell. Dev. Biol.30, 255–289 (2014).
   PubMed Web of Science ®Google Scholar
• Lo Cicero A , StahlPD, RaposoG. Extracellular vesicles shuffling intercellular messages: for good or for bad. Curr. Opin. Cell Biol.35, 69–77 (2015).
   PubMed Web of Science ®Google Scholar
• Tkach M , TheryC. Communication by extracellular vesicles: where we are and where we need to go. Cell164 (6), 1226–1232 (2016).
   PubMed Web of Science ®Google Scholar
• De Toro J , HerschlikL, WaldnerC, MonginiC. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front. Immunol.6, 203 (2015).
   PubMed Web of Science ®Google Scholar
• Srivastava A , BabuA, FilantJet al. Exploitation of exosomes as nanocarriers for gene-, chemo-, and immune-therapy of cancer. J. Biomed. Nanotechnol.12 (6), 1159–1173 (2016).
   PubMed Web of Science ®Google Scholar
• Tominaga N , YoshiokaY, OchiyaT. A novel platform for cancer therapy using extracellular vesicles. Adv. Drug. Deliver. Rev.95, 50–55 (2015).
   PubMed Web of Science ®Google Scholar
• Jang SC , KimOY, YoonCMet al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano7 (9), 7698–7710 (2013).
   PubMed Web of Science ®Google Scholar
• Wan Y , WangLX, ZhuCDet al. Aptamer-conjugated extracellular nanovesicles for targeted drug delivery. Cancer Res.78 (3), 798–808 (2018).
   PubMed Web of Science ®Google Scholar
• Maguire CA , BalajL, SivaramanSet al. Microvesicle-associated AAV vector as a novel gene-delivery system. Mol. Ther.20 (5), 960–971 (2012).
   PubMed Web of Science ®Google Scholar
• Greco KA , FranzenCA, ForemanKE, FlaniganRC, KuoPC, GuptaGN. PLK-1 silencing in bladder cancer by siRNA delivered with exosomes. Urology91, 241.e1–241.e7 (2016).
   PubMed Web of Science ®Google Scholar
• Kim MS , HaneyMJ, ZhaoYet al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed. Nanotechnol. Biol. Med.12 (3), 655–664 (2016).
   PubMed Web of Science ®Google Scholar
• Pascucci L , CocceV, BonomiAet al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J. Control. Rel.192, 262–270 (2014).
   PubMed Web of Science ®Google Scholar
• Wang XY , ZhangHY, BaiMet al. Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer. Mol. Ther.26 (3), 774–783 (2018).
   PubMed Web of Science ®Google Scholar
• Aqil F , JeyabalanJ, AgrawalAKet al. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer. Food Funct.8 (11), 4100–4107 (2017).
   PubMed Web of Science ®Google Scholar
• Ohno S , TakanashiM, SudoKet al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther.21 (1), 185–191 (2013).
   PubMed Web of Science ®Google Scholar
• Yang T , MartinP, FogartyBet al. Exosome delivered anticancer drugs across the blood–brain barrier for brain cancer therapy in Danio rerio. Pharm. Res.32 (6), 2003–2014 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang H , WangY, BaiMet al. Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer Sci.109 (3), 629–641 (2018).
   PubMed Web of Science ®Google Scholar
• Ye Z , ZhangT, HeWet al. Methotrexate-loaded extracellular vesicles functionalized with therapeutic and targeted peptides for the treatment of glioblastoma multiforme. ACS Appl. Mater. Interfaces10 (15), 12341–12350 (2018).
   PubMed Web of Science ®Google Scholar
• Wahlgren J , DeLKT, BrisslertMet al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res.40 (17), e130 (2012).
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L , SeowY, YinH, BettsC, LakhalS, WoodMJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol.29 (4), 341–345 (2011).
   PubMed Web of Science ®Google Scholar
• Pan Q , RamakrishnaiahV, HenrySet al. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut61 (9), 1330–1339 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang Y , LiuD, ChenXet al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell39 (1), 133–144 (2010).
   PubMed Web of Science ®Google Scholar
• Bryniarski K , PtakW, JayakumarAet al. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J. Allergy Clin. Immunol.132 (1), 170–181 (2013).
   PubMed Web of Science ®Google Scholar
• Chen L , CharrierA, ZhouYet al. Epigenetic regulation of connective tissue growth factor by microRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology59 (3), 1118–1129 (2014).
   PubMed Web of Science ®Google Scholar
• Zhuang X , XiangX, GrizzleWet al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther.19 (10), 1769–1779 (2011).
   PubMed Web of Science ®Google Scholar
• Sun D , ZhuangX, XiangXet al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther.18 (9), 1606–1614 (2010).
   PubMed Web of Science ®Google Scholar
• Mizrak A , BolukbasiMF, OzdenerGBet al. Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol. Ther.21 (1), 101–108 (2013).
   PubMed Web of Science ®Google Scholar
• Munoz JL , BlissSA, GrecoSJ, RamkissoonSH, LigonKL, RameshwarP. Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol. Ther. Nucl. Acids2, e126 (2013).
   Google Scholar
• Wang JH , ZhengYJ, ZhaoM. Exosome-based cancer therapy: implication for targeting cancer stem cells. Front. Pharmacol.7, 533 (2017).
   PubMed Web of Science ®Google Scholar
• Webber J , YeungV, ClaytonA. Extracellular vesicles as modulators of the cancer microenvironment. Semin. Cell Dev. Biol.40, 27–34 (2015).
   PubMed Web of Science ®Google Scholar
• Greening DW , GopalSK, XuR, SimpsonRJ, ChenWS. Exosomes and their roles in immune regulation and cancer. Semin. Cell Dev. Biol.40, 72–81 (2015).
   PubMed Web of Science ®Google Scholar
• Qu JL , QuXJ, ZhaoMFet al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Digest. Liver Dis.41 (12), 875–880 (2009).
   Web of Science ®Google Scholar
• Wei YF , LaiXF, YuSTet al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res. Treat.147 (2), 423–431 (2014).
   PubMed Web of Science ®Google Scholar
• Corcoran C , RaniS, O’BrienKet al. Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS ONE7 (12), e50999 (2012).
   PubMed Web of Science ®Google Scholar
• Bach DH , HongJY, ParkHJ, LeeSK. The role of exosomes and miRNAs in drug-resistance of cancer cells. Int. J. Cancer141 (2), 220–230 (2017).
   PubMed Web of Science ®Google Scholar
• Namee NM , O’DriscollL. Extracellular vesicles and anti-cancer drug resistance. Biochim. Biophys. Acta Rev. Cancer doi: 10.1016/j.bbcan.2018.07.003 (2018) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Kamerkar S , LebleuVS, SugimotoHet al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature546 (7659), 498–503 (2017).
   PubMed Web of Science ®Google Scholar
• Steinbichler TB , DudasJ, RiechelmannHet al. The role of exosomes in cancer metastasis. Semin. Cancer Biol.44, 170–181 (2017).
   PubMed Web of Science ®Google Scholar
• Weidle UH , BirzeleF, KollmorgenG, RugerR. The multiple roles of exosomes in metastasis. Cancer Genomics Proteomics14 (1), 1–15 (2017).
   PubMed Web of Science ®Google Scholar
• Wang J , SunX, ZhaoJet al. Exosomes: a novel strategy for treatment and prevention of diseases. Front. Pharmacol.8, 300 (2017).
   PubMed Web of Science ®Google Scholar
• Gilligan KE , DwyerRM. Engineering exosomes for cancer therapy. Int. J. Mol. Sci.18 (6), 1122 (2017).
   PubMed Web of Science ®Google Scholar
• Moher D , LiberatiA, TetzlaffJ, AltmanDG, GrpP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med.6 (7), e1000100 (2009).
   PubMed Web of Science ®Google Scholar
• Lotvall J , HillAF, HochbergFet al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles3, 26913 (2014).
   PubMedGoogle Scholar
• Shtam TA , KovalevRA, VarfolomeevaEY, MakarovEM, KilYV, FilatovMV. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun. Signal.11, 88 (2013).
   PubMed Web of Science ®Google Scholar
• Hosseini HM , FooladiAaI, SoleimaniradJ, NouraniMR, MahdaviM. Exosome/staphylococcal enterotoxin B, an anti-tumor compound against pancreatic cancer. J. Buon.19 (2), 440–448 (2014).
   PubMed Web of Science ®Google Scholar
• O’Brien K , LowryMC, CorcoranCet al. miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. Oncotarget6 (32), 32774–32789 (2015).
   PubMed Web of Science ®Google Scholar
• Saari H , Lazaro-IbanezE, ViitalaT, Vuorimaa-LaukkanenE, SiljanderP, YliperttulaM. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells. J. Control. Rel.220, 727–737 (2015).
   PubMed Web of Science ®Google Scholar
• Srivastava A , AmreddyN, BabuAet al. Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells. Sci. Rep.6, 38541 (2016).
   PubMed Web of Science ®Google Scholar
• Tang K , ZhangY, ZhangHFet al. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat. Commun.3, 1282 (2012).
   PubMed Web of Science ®Google Scholar
• Kim SM , YangY, OhSJ, HongY, SeoM, JangM. Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting. J. Control. Rel.266, 8–16 (2017).
   PubMed Web of Science ®Google Scholar
• Ran L , TanXH, LiYCet al. Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials89, 56–66 (2016).
   PubMed Web of Science ®Google Scholar
• Hadla M , PalazzoloS, CoronaGet al. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine (Lond.)11 (18), 2431–2441 (2016).
   PubMed Web of Science ®Google Scholar
• Smyth T , KullbergM, MalikN, Smith-JonesP, GranerMW, AnchordoquyTJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J. Control. Rel.199, 145–155 (2015).
   PubMed Web of Science ®Google Scholar
• Ma JW , ZhangY, TangKet al. Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles. Cell Res.26 (6), 713–727 (2016).
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K , MeehanB, MicallefJet al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol.10 (5), 619–624 (2008).
   PubMed Web of Science ®Google Scholar
• Nazarenko I , RanaS, BaumannAet al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res.70 (4), 1668–1678 (2010).
   PubMed Web of Science ®Google Scholar
• Rana S , YueS, StadelD, ZollerM. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int. J. Biochem. Cell Biol.44 (9), 1574–1584 (2012).
   PubMed Web of Science ®Google Scholar
• Muralidharan-Chari V , ClancyJW, SedgwickA, D’souza-SchoreyC. Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci.123 (Pt 10), 1603–1611 (2010).
   PubMed Web of Science ®Google Scholar
• Ren J , HeW, ZhengL, DuanH. From structures to functions: insights into exosomes as promising drug delivery vehicles. Biomater. Sci.4 (6), 910–921 (2016).
   PubMed Web of Science ®Google Scholar
• Willingham SB , VolkmerJP, GentlesAJet al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl Acad. Sci. USA109 (17), 6662–6667 (2012).
   PubMed Web of Science ®Google Scholar
• Mccracken MN , ChaAC, WeissmanIL. Molecular pathways: activating T cells after cancer cell phagocytosis from blockade of CD47 ‘Don’t Eat Me’ signals. Clin. Cancer Res.21 (16), 3597–3601 (2015).
   PubMed Web of Science ®Google Scholar
• Raposo G , StoorvogelW. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol.200 (4), 373–383 (2013).
   PubMed Web of Science ®Google Scholar
• Kibria G , RamosEK, LeeKEet al. A rapid, automated surface protein profiling of single circulating exosomes in human blood. Sci Rep6, 36502 (2016).
   PubMed Web of Science ®Google Scholar
• Kaiser J . Malignant messengers. Science352 (6282), 164–166 (2016).
   PubMed Web of Science ®Google Scholar
• Lorenzer C , DirinM, WinklerAM, BaumannV, WinklerJ. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics. J. Control. Rel.203, 1–15 (2015).
   PubMed Web of Science ®Google Scholar
• Peinado H , ZhangHY, MateiIRet al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer17 (5), 302–317 (2017).
   PubMed Web of Science ®Google Scholar
• Gangoda L , BoukourisS, LiemM, KalraH, MathivananS. Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic?Proteomics15 (2-3), 260–271 (2015).
   PubMed Web of Science ®Google Scholar
• Valadi H , EkstromK, BossiosA, SjostrandM, LeeJJ, LotvallJO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol.9 (6), 654–659 (2007).
   PubMed Web of Science ®Google Scholar
• Zhu W , HuangL, LiYet al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett.315 (1), 28–37 (2012).
   PubMed Web of Science ®Google Scholar
• Herrera Sanchez MB , BrunoS, GrangeCet al. Human liver stem cells and derived extracellular vesicles improve recovery in a murine model of acute kidney injury. Stem Cell Res. Ther.5 (6), 124 (2014).
   PubMed Web of Science ®Google Scholar
• Nawaz M , FatimaF, VallabhaneniKCet al. Extracellular vesicles: evolving factors in stem cell biology. Stem Cells Int.2016, 1073140 (2016).
   PubMed Web of Science ®Google Scholar
• Costa-Silva B , AielloNM, OceanAJet al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol.17 (6), 816–826 (2015).
   PubMed Web of Science ®Google Scholar
• Hoshino A , Costa-SilvaB, ShenTLet al. Tumour exosome integrins determine organotropic metastasis. Nature527 (7578), 329–335 (2015).
   PubMed Web of Science ®Google Scholar
• Peinado H , AleckovicM, LavotshkinSet al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med.18 (6), 883–891 (2012).
   PubMed Web of Science ®Google Scholar
• Sena ES , Van Der WorpHB, BathPM, HowellsDW, MacleodMR. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS. Biol.8 (3), e1000344 (2010).
   PubMed Web of Science ®Google Scholar
• Dirnagl U , LauritzenM. Fighting publication bias: introducing the negative results section. J. Cereb. Blood Flow Metab.30 (7), 1263–1264 (2010).
   PubMed Web of Science ®Google Scholar
• Li P , KaslanM, LeeSH, YaoJ, GaoZQ. Progress in exosome isolation techniques. Theranostics7 (3), 789–804 (2017).
   PubMed Web of Science ®Google Scholar
• Shao HL , ImH, CastroCM, BreakefieldX, WeisslederR, LeeHH. New technologies for analysis of extracellular vesicles. Chem. Rev.118 (4), 1917–1950 (2018).
   PubMed Web of Science ®Google Scholar
• Cheng Y , ZengQ, HanQ, XiaW. Effect of pH, temperature and freezing–thawing on quantity changes and cellular uptake of exosomes. Protein Cell doi: 10.1007/s13238-018-0529-4 (2018) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Lee M , BanJJ, ImW, KimM. Influence of storage condition on exosome recovery. Biotechnol. Bioprocess Eng.21 (2), 299–304 (2016).
   Web of Science ®Google Scholar
• Akers JC , RamakrishnanV, YangIet al. Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid. Cancer Biomark.17 (2), 125–132 (2016).
   PubMed Web of Science ®Google Scholar
• Zhao Y , ChenKY, LiHN, WuHY. Effect of pH on the isolation of urinary exosome. Int. Urol. Nephrol.49 (1), 165–169 (2017).
   PubMed Web of Science ®Google Scholar
• Ban JJ , LeeM, ImW, KimM. Low pH increases the yield of exosome isolation. Biochem. Bioph. Res. Co.461 (1), 76–79 (2015).
   PubMed Web of Science ®Google Scholar
• Syn NL , WangLZ, ChowEKH, LimCT, GohBC. Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends Biotechnol.35 (7), 665–676 (2017).
   PubMed Web of Science ®Google Scholar
• Lamichhane TN , JeyaramA, PatelDBet al. Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication. Cell. Mol. Bioeng.9 (3), 315–324 (2016).
   PubMed Web of Science ®Google Scholar
• Kooijmans SaA , StremerschS, BraeckmansKet al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J. Control. Rel.172 (1), 229–238 (2013).
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F , BalaS, BukongT, SzaboG. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomed. Nanotechnol. Biol. Med.10 (7), 1517–1527 (2014).
   PubMed Web of Science ®Google Scholar
• Li L , PiontekK, IshidaMet al. Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model. Hepatology65 (2), 501–514 (2017).
   PubMed Web of Science ®Google Scholar
• Kim MS , HaneyMJ, ZhaoYLet al. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomed. Nanotechnol. Biol. Med.14 (1), 195–204 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang HY , WangY, BaiMet al. Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer Sci.109 (3), 629–641 (2018).
   PubMed Web of Science ®Google Scholar
• Ohno S , TakanashiM, SudoKet al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther.21 (1), 185–191 (2013).
   PubMed Web of Science ®Google Scholar
• Tian YH , LiSP, SongJet al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials35 (7), 2383–2390 (2014).
   PubMed Web of Science ®Google Scholar
• Van Der Meel R , FensMHaM, VaderPet al. Extracellular vesicles as drug delivery systems: lessons from the liposome field. J. Control. Rel.195, 72–85 (2014).
   PubMed Web of Science ®Google Scholar
• Takahashi Y , NishikawaM, ShinotsukaHet al. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J. Biotechnol.165 (2), 77–84 (2013).
   PubMed Web of Science ®Google Scholar
• Mendt M , KamerkarS, SugimotoHet al. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight doi: 10.1172/jci.insight.99263 (2018) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Lener T , GimonaM, AignerLet al. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper. J. Extracell. Vesicles4, 30087 (2015).
   PubMed Web of Science ®Google Scholar
• Fais S , O’DriscollL, BorrasFEet al. Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine. ACS Nano10 (4), 3886–3899 (2016).
   PubMed Web of Science ®Google Scholar